Amylin Pharmaceuticals, Inc.

United States

Amylin Pharmaceuticals was a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company was engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Amylin produced three drugs: Symlin (pramlintide acetate), Byetta (exenatide) and Bydureon (exenatide extended-release).

 More from Wikipedia

Metrics Summary

Total Publications

Lifetime

641

Prior Five Years

Total Citations

Lifetime

30,009

Prior Five Years

Total Scholars

Lifetime

241

Prior Five Years

N/A

Non-academic Institutional Ranking

Global Overall (All Fields)

Worldwide

Lifetime

4288

Prior Five Years

N/A

National Overall (All Fields)

United States

Lifetime

533

Prior Five Years

N/A

Institutional Rankings

Fields, Disciplines and Specialties

Lifetime

View

Prior Five Years

N/A

Evaluation Period:

		Global Specialty Lifetime
N/A	N/A	#1	Vascular resistance
		#2	Glucose uptake
		#18	Insulin resistance
		#19	Skeletal muscle
		#39	Insulin
		#44	Glucose
		#48	Hemodynamics
		#80	Metabolism
		#98	Obesity


N/A	N/A	N/A

Publications and Citation History

Publications based on Fields

Scholars based on Fields

Publications based on Top 20 Disciplines

Scholars based on Top 20 Disciplines

Evaluation Period:

Highly Ranked Scholars™

Overall (All Fields)

Lifetime

Field

Lifetime

Discipline

Lifetime

Specialty

Lifetime

Top Scholars by Institution

Evaluation Period:

Highly Cited Publications

Lifetime